CEACAM5 and prostate cancer: Based on this, Chen et al. developed a multiplex vertical flow SERS assay to detect different biomarkers of prostate cancer (prostate-specific antigen (PSA), carcinoembryonic antigen (CEA), and alpha-fetoprotein (AFP)) simultaneously in a single test spot [155].